POLATUZUMAB VEDOTIN

10202 reported adverse events

These side effects are most commonly reported by patients taking POLATUZUMAB VEDOTIN:

# Side effect Count
0 DISEASE PROGRESSION 2064
1 OFF LABEL USE 1398
2 DEATH 801
3 NEUTROPENIA 642
4 ANAEMIA 577
5 COVID-19 549
6 FEBRILE NEUTROPENIA 549
7 CYTOKINE RELEASE SYNDROME 542
8 PYREXIA 531
9 DRUG INEFFECTIVE 503
See all common reactions for POLATUZUMAB VEDOTIN

POLATUZUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 391 0.1772
1 FOLLICULAR LYMPHOMA RECURRENT 11 0.1375
2 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 114 0.1204
3 LYMPHOMA TRANSFORMATION 40 0.1111
4 REFRACTORY CANCER 17 0.0794
5 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 26 0.0793
6 CYSTITIS VIRAL 24 0.0627
7 DIFFUSE LARGE B-CELL LYMPHOMA 428 0.0555
8 FOLLICULAR LYMPHOMA 45 0.0511
9 CANDIDA PNEUMONIA 16 0.0495
See all enriched reactions for POLATUZUMAB VEDOTIN